Posted by AGORACOM
at 10:54 AM on Monday, April 19th, 2021
Company’s common shares will begin trading on the OTCQB® Venture Market (“OTCQB”) today, April 19, 2021 under the current stock symbol “DTMXF”
Marshall Gunter, CEO of Datametrex AI Limited, “With the Company’s shares now quoted on the OTCQB, it will enhance our visibility and make the Company’s shares available to a much larger group of U.S. investors. “
Toronto, Ontario–(Newsfile Corp. – April 19, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that after a successful application process for the OTCQB® Venture Market (“OTCQB”), the Company’s common shares will begin trading on the OTCQB today, April 19, 2021, at the opening of the market under the current stock symbol “DTMXF” and will remain listed on the TSX Venture Exchange under the ticker symbol “DM”.
Existing U.S. shareholders of Datametrex AI Limited shares, previously quoted on the OTC® Pink Open Market, will now be quoted on the OTCQB without any further action needed.
Marshall Gunter, CEO of Datametrex AI Limited, “With the Company’s shares now quoted on the OTCQB, it will enhance our visibility and make the Company’s shares available to a much larger group of U.S. investors. The quotation on the OTCQB is anticipated to enhance liquidity by providing current and prospective investors with an easily accessible and transparent trading platform where they go and obtain Real Time quotes and market information.”
About OTCQB
The OTCQB® Venture Market is the premier marketplace for entrepreneurial and development stage US and international companies that are committed to providing a high-quality trading and information experience for their US investors. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors. The ability to have the Company’s shares electronically transferred between brokerages in the US is significantly more convenient and reduces the costs incurred in trading shares. When shares are able to trade electronically, existing investors benefit from greater liquidity and execution speeds, while opening the door to new investors that may have been previously restricted from the Company’s shares.
Posted by AGORACOM-JC
at 8:30 AM on Friday, April 16th, 2021
Announce the receipt of TSXV approval and completion, on April 14, 2021, of the acquisition of mediahelden GmbH d/b/a/ Passcreator by Loop.
Due to rounding, the number of common shares of Loop issued as consideration was revised to 1,301,425, all other consideration paid as set out in the prior news release remains the same.
VANCOUVER, British Columbia, April 16, 2021 — Further to the Company’s press release dated March 29, 2021, Loop Insights Inc. (TSXV: MTRX; OTCQB: RACMF) (the “ Company ” or “ Loop ”), a provider of contactless solutions and artificial intelligence (“ AI ”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick and mortar space, is pleased to announce the receipt of TSXV approval and completion, on April 14, 2021, of the acquisition of mediahelden GmbH d/b/a/ Passcreator by Loop. Due to rounding, the number of common shares of Loop issued as consideration was revised to 1,301,425, all other consideration paid as set out in the prior news release remains the same.
About Passcreator
Passcreator is a German wallet pass software company that offers clients a software as a service solution for mobile marketing. Compatible with wallet apps on both iOS and Android, Passcreator seamlessly integrates with existing marketing platforms, as well as supports the creation of new ones. Furthermore, Passcreator is fully GDPR compliant and highly scalable. This solution is suitable for companies of all sizes.
About Loop
Loop is a Vancouver-based Internet of Things (” IoT “) technology company that delivers transformative artificial intelligence (” AI “) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real- time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network and sold through the TELUS IoT Marketplace.
Posted by AGORACOM-JC
at 8:16 AM on Thursday, April 15th, 2021
Company Stock Is Now More Accessible to U.S. Investors
United States investors may now more easily trade Empower’s OTC stock (OTC PINK:EPWCF) in addition to Empower’s listing on the CSE (CSE:CBDT) and (FRA:8EC).
VANCOUVER B.C. / April 15, 2021 /EMPOWER CLINICS INC. (CSE:CBDT)(FRA:8EC)(OTC PINK:EPWCF) (“Empower” or the “Company”) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens – is pleased to announce it is now eligible for Depository Trust Company (“DTC”) services in relation to Empower’s listing on the OTC.
United States investors may now more easily trade Empower’s OTC stock (OTC PINK:EPWCF) in addition to Empower’s listing on the CSE (CSE:CBDT) and (FRA:8EC).
“Convenience is a core part of Empower’s overall strategy for our approach to integrated healthcare, so our capital markets strategy should be the same. I’m thrilled that trading Empower’s shares will now be easier for existing and potential shareholders in the U.S.,” said Steven McAuley, Chairman & CEO of Empower. “Empower has a strong and growing presence in the United States market operationally as well as for investors. We’re confident that we will see enhanced trading liquidity as a result of our DTC eligibility.”
DTC is a subsidiary of the Depository Trust and Clearing Corporation (DTCC), one of the world’s largest securities depositories that manages the electronic clearing and settlement of publicly traded companies. Empower is now eligible to be electronically cleared and settled through the DTC and is therefore considered “DTC eligible”. This electronic method of clearing securities streamlines the process of trading, enhances liquidity, and provides direct access to investors and brokers in the U.S. OTC capital markets.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
Posted by AGORACOM-JC
at 8:41 AM on Wednesday, April 14th, 2021
Forecourt operators to get access to real-time data from any point-of-sale through Loop’s IoT device
Announces a new Proof of Concept (PoC) with Suresite Group
The cooperation will see selected Suresite retail locations take advantage of Loop’s IoT Fobi device and Insights platform
LONDON and VANCOUVER, British Columbia, April 14, 2021 — Loop Insights (MTRX:TSXV; RACMF:OTCQB), a provider of contactless solutions and artificial intelligence for the brick and mortar space, announces a new Proof of Concept (PoC) with Suresite Group. The cooperation will see selected Suresite retail locations take advantage of Loop’s IoT Fobi device and Insights platform.
Loop Insights is growing its UK retail presence
According to KPMG , the UK’s forecourt or gas station convenience store sector generates approximately £4.5 billion in annual revenue. Loop’s latest agreement with Suresite represents its entry into the UK’s retail energy sectors, as part of wider business development efforts in the UK.
The changing trends of forecourt retail
Suresite ’s UK data of card payment transactions and spend show that in the last 12 months, there has been less demand for fuel with people unable to travel due to local and national lockdowns. Yet these travel restrictions have also led to a growth in non-fuel retail with customers choosing to carry out their grocery shopping locally at nearby fuel stations, looking to fulfil multiple purposes in a single trip with an increased appetite for cashless transactions. With the constantly changing trends and challenges brought by the pandemic, data insights are now more important for forecourt retail than ever.
Loop’s Fobi is an IoT device working with an AI-powered retail analytics platform that allows retailers unprecedented access to real-time transaction data from any point-of-sale (POS) – online, in-store, and across multiple properties.
During the PoC, Loop Insights will implement its Fobi device and Insights AI-powered analytics platform across numerous Suresite client locations. This will provide Suresite, and more importantly, its clients who operate leading fuel and convenience brands, with powerful, actionable data capabilities needed to deliver informed loyalty experience and drive operational efficiencies. Suresite’s forecourt client market currently includes major brands such as Harvest Energy, Gulf, Jet, and others.
“ Through services such as our real-time, data-driven fuel monitoring solution, Suresite understands that retailers need data to be delivered in real-time to be able to maximise revenue and wallet-share. For the retailer, it’s about understanding the shopping basket breakdown item by item, who made the purchase, and how. Or having the ability to see how a special promotion is performing in real time so adjustments can be made if needed. This is why Suresite has partnered with Loop Insights, to help our clients improve their business decisions based on real-time, actionable insights,” explains Eva Jones, Head of Product Development and Innovation at Suresite.
Loop Insights CEO Rob Anson stated: “Our latest Proof of Concept agreement with Suresite is additional proof that our Fobi device combined with our AI-powered Insights platform serves an immediate, data driven need in the convenience and fuel sectors. Recent announcements with Sobeys in grocery, and now Suresite in convenience and fuel – two of the largest retail sectors in the world – serve notice that Loop and its solutions are fit-for-purpose in today’s data-first world. We anticipate this PoC will be another massive success for both Loop and Suresite as we continue to demonstrate the power of Loop’s Insights platform no matter the industry or country.”
Suresite CEO Steve Hoban added: “We understand the power of insight to help our clients improve their offer, sales and profit. We are excited to partner with Loop and are looking forward to the results of our trials. Our aim is to continue to add value to our clients and be able to enrich our data to provide them with insights that help them grow.”
This press release is available on the Loop Insights Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/LoopInsights .
About Suresite Group Established over 25 years ago, Suresite Group provides a range of business critical operational services for Fuel and Convenience Retailers. Suresite market leading Payment and data solutions, Wetstock management, Training and Health & Safety compliance help over 3,000 stores across the UK run businesses more effectively. Suresite Group customers and partners include Barclays, Worldpay, Timico, Feefo, American Express, Sponge, Greenergy, Cost Cutter, Jet, and others.
About Loop Insights Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”), automated marketing, venue tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.
This news release contains certain statements that constitute forward-looking statements or information, including statements regarding Loop’s business and technology; the ability of Loop to engage with industry participants to achieve its goals; the development of Loop’s technology; and the viability of Loop’s business model. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, competition from other industry participants, stock market volatility, and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated, or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity, or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 8:36 AM on Wednesday, April 14th, 2021
Announced that Kai Medical Laboratory has received an order for COVID-19 RT-PCR tests that is anticipated to be in excess of $CAD 750,000 from two new film and television productions.
VANCOUVER, BC / April 14, 2021 / EMPOWER CLINICS INC. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce that Kai Medical Laboratory (“KAI”) has received an order for COVID-19 RT-PCR tests that is anticipated to be in excess of $CAD 750,000 from two new film and television productions.
5,000 TEST ORDER FOR FILM & TELEVISION PRODUCTIONS REPRESENTS REPEAT ORDER BASED ON CONSISTENT PERFORMANCE OF KAI MEDICAL LAB
In early October, shortly after the acquisition of KAI, Empower announced an agreement to process approximately 1,000 COVID-19 RT-PCR tests for a major film & TV production over a 30-day period, with the possibility of more business upon successful completion of the initial tests.
On November 16, 2020 KAI received a repeat and record COVID-19 testing order for approximately 9,000 units in excess of $CAD 1,000,000 over a four-month period.
Today’s announcement represents a repeat Purchase Order of approximately 5,000 units to be processed over just a two-month period. The total revenue from this order is anticipated to be in excess of $CAN 750,000.
“Our team at KAI continues to deliver the type of performance to Tier-1 clients that is worthy of significant repeat business that serves as unequivocal validation of our capabilities,” said Steven McAuley, Chairman & CEO of Empower. “To this end, the magnitude of KAI’s growth and success cannot be overstated as it continues to focus on very active business development and product development, setting a path toward significant North American growth in the midst of tripling its size. KAI is well on its way to becoming a national brand supported by our strong working capital position and a team dedicated to performance.”
As of September 1st, KAI has already processed tests for multiple different film and television productions in key US markets including Los Angeles, Atlanta, New York, Dallas, earning the highest confidence of the industry.
KAI MEDICAL LABORATORY NOW EXPANDING TO TRIPLE CURRENT SIZE IN ANTICIPATION OF ANTICIPATED RAPID TEST GROWTH
KAI continues to progress on the design and build out of the laboratory expansion to prepare to meet upcoming demand in a number of areas. First, the continued processing of RT-PCR tests for film & television productions, commercial accounts and enterprise level clients. Second, the full e-commerce impact of KaiTests.com and the national direct-to-consumer marketing programs for KAI Saliva, an FDA, EUA authorized and Health Canada approved at-home Saliva COVID-19 RT-PCR Test. KAI Saliva provides travellers, both foreign and domestic with a simple, fully compliant method to obtain an RT-PCR test and test result prior to arriving or coming back into Canada and USA, or arriving in other countries that have similar executive travel orders.
Finally, KAI Labs continues the development of new direct-to-consumer test protocols that will expand the product offers on Kaitests.com throughout 2021 and beyond.
McAuley added “With each passing month Empower gains more strength and velocity in every aspect of our business from KAI Lab in Dallas to our rapidly expanding clinic operations in Canada and our direct-to-consumer products such as KAI Saliva. All of which are amply funded well into the future with our strongest balance sheet ever thanks to the receipt of more than $12,000,000 in warrant conversions as of last month. We are on a path, a trajectory towards building a great health and wellness company across North America, and I look forward to providing our shareholders with further specifics.”
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
Tags: covid19, Covid19 testing, CSE, Diagnos Inc, investments, small cap Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca $EPWCF Kai Medical Lab Receives Order for Up To 5,000 Covid-19 Tests from Two Film & Television Productions in Excess Of $750,000 $DMTK $LMD.ca $DOC.ca $DOCRF $WELL.ca $PRN.ca
Posted by AGORACOM-JC
at 8:29 AM on Tuesday, April 13th, 2021
Announced it has appointed Ms. Yoshi Tyler to its board of directors.
With a professional and entrepreneurial background in healthcare, Ms. Tyler has more than 13 years of experience providing leadership at Pfizer, Inc., a Fortune 500 pharmaceutical company.
This experience has provided her with in-depth knowledge and industry insights to found and lead Kai Medical Laboratory towards unprecedented growth.
VANCOUVER, BC / April 13, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens – is pleased to announce it has appointed Ms. Yoshi Tyler to its board of directors.
With a professional and entrepreneurial background in healthcare, Ms. Tyler has more than 13 years of experience providing leadership at Pfizer, Inc., a Fortune 500 pharmaceutical company. This experience has provided her with in-depth knowledge and industry insights to found and lead Kai Medical Laboratory towards unprecedented growth. Empower fully acquired Kai Medical Laboratory in October 2020.
“We are delighted to welcome Yoshi as a valued addition to our board of directors,” said Steven McAuley, Chairman & CEO of Empower. “Having diverse leadership continues to improve our company and since our acquisition of Kai Medical Laboratory, Yoshi has led her team to surpass initial growth forecasts and demonstrated an incredible work ethic and passion for excellence. I am privileged to now count Yoshi as a fellow board member in recognition of her talent, performance and passion.”
“I’m thrilled to be contributing to the growth of Empower at another level of the company,” said Yoshi Tyler. “After only a few months as part of the Empower team, I’ve witnessed the benefits of our synergies and know firsthand about the incredible potential we have to become a leading integrated health care company in North America.”
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
Posted by AGORACOM-JC
at 8:19 AM on Thursday, April 8th, 2021
Snow Agency recognized as #1 U.S. digital marketing agency
Announced a partnership with Snow Agency to launch its direct-to-consumer (DTC) e-commerce solutions.
Snow Agency is a performance digital marketing and creative agency whose customized brand strategies and content production maximize the impact of direct response ads and creatives on Facebook/Instagram, Google/YouTube, Snapchat, and Email/SMS
Collaboration will allow Empower patients, existing and prospective, to benefit from an accessible, seamless and educative experience when purchasing at-home diagnostics test kits
VANCOUVER BC / April 8, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens – today announced a partnership with Snow Agency to launch its direct-to-consumer (DTC) e-commerce solutions.
The Snow Agency is a performance digital marketing and creative agency whose customized brand strategies and content production maximize the impact of direct response ads and creatives on Facebook/Instagram, Google/YouTube, Snapchat, and Email/SMS. To date, they’ve brought in more than $250 million USD in sales for their clients. The Snow Agency has been recognized on Yahoo! Finance ranked as the #1 US Digital Marketing Agency & Digital Agency in January 2021 by Design Rush, a top B2B marketplace connecting brands with agencies.
The collaboration will allow Empower patients, existing and prospective, to benefit from an accessible, seamless and educative experience when purchasing at-home diagnostics test kits. Today patients can purchase at-home COVID-19 saliva test kits by phone or email at www.kaitests.com.
“Empower is committed to make our solutions as convenient as possible to all patients in North America. A DTC e-commerce solution is a key part of that solution.” said Steven McAuley, Chairman & CEO of Empower. “I am privileged to now count Snow Agency as a partner in our journey to deliver at-home testing solutions and empower patients to take control of their own health data. Even with vaccines, ongoing testing is desperately needed because more testing, along with mask-wearing and physical distancing, will get people back into offices, planes and classrooms and help catch cases that go undetected”.
“This partnership is really making a positive difference in people’s lives. We know that we can reach millions of consumers with success for brands. We see our partnership with Empower as our contribution from Snow Agency to help reopen the economy, allow people to travel with confidence and getting back to normal life.” said Dan Snow, CEO and Co-founder of Snow Agency.
“As a trained physician and a digital marketing entrepreneur, I fully believe in Empower’s at-home diagnostic testing solutions especially its integrated laboratory services at Kai Medical. It’s the time now to digitally transform healthcare, focus on accessibility and convenience for patients and save valuable time and money on stretched public health services. People will need to get tested regularly so we can all get back to normal” said Dr. Jonathan Snow, COO and Co-founder of Snow Agency.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
ABOUT EMPOWER:
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
Investors: Tamara Mason Business Development & Communications [email protected] 416-671-5617
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the acquisition of Kai Medical Laboratory; the transaction terms; the expected number of clinics and patients following the closing; the future potential success of Kai Medical Laboratory, Sun Valley’s franchise model; launch of new healthcare centers and the occurrence thereof; that the Company can bring healthcare to millions of Canadians; that new healthcare services can be added and that the Company will be positioned to be a market- leading service provider for complex patient requirements in 2020 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that Kai Medical Laboratory will successfully win any US Government RFP; that the MedX Health pilot program will be successful; that Empower will place the MedX Health teledermatology product in health centers in North America; that the Company’s products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for Canadian clinics or Kai Medical Laboratory expansion inn 2Q 2021; that general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.
Posted by AGORACOM-JC
at 8:00 AM on Wednesday, April 7th, 2021
Announced the Company has completed its integration to Vend’s Billing API, providing Vend retailers with seamless onboarding to Loop’s multi-domain, franchise compliance, and historical reporting solutions
VANCOUVER, British Columbia, April 07, 2021 — Loop Insights Inc. (MTRX:TSXV RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights and enhanced customer engagement to the brick and mortar space, is pleased to announce the Company has completed its integration to Vend’s Billing API, providing Vend retailers with seamless onboarding to Loop’s multi-domain, franchise compliance, and historical reporting solutions.
Loop Insights First to Integrate with Vend’s Billing API, Providing a Seamless Onboarding Option for Vend’s Global Client List of over 20,000 Customer Locations Worldwide
Vend Director of Product Partnerships Lowry Gladwell stated: “The completion of Loop’s integration with the Vend Billing API is an example of how Vend works closely with partners to deliver value for our retailers. It has been great to see Loop’s enthusiasm for the project and we’re thrilled that our Vend retailers can now onboard clients to benefit from Loop’s products and services faster than ever before, giving them easier access to the multi-domain, franchise and historical reporting that Loop offers. Additionally, our announced acquisition by Lightspeed, which is expected to close towards the end of April, will allow Vend and Loop to reach new clients, with a particular focus on expansion in Asia-Pacific. I look forward to connecting Vend’s expanding customer base with Loop’s amazing solution stack.”
Loop Insights CEO Rob Anson stated: “Vend’s support of Loop’s integration to their Billing API speaks volumes about its confidence in Loop and our retail solutions. With the development of our Billing API integration now complete, both Loop and Vend are positioned to generate new sales opportunities through this successful partnership. Loop’s retail Insights service can now be onboarded to over 20,000 Vend customer locations, with the ability to scale to support Lightspeed’s 135,000 worldwide locations through Lightspeed’s recent acquisition of Vend. This API integration represents a massive revenue-generating opportunity for Loop, Vend, Lightspeed, and their many customers.”
Loop Insights is the first company to complete a full billing API integration with Vend, reflecting Vend’s confidence in Loop’s products and their ability to deliver value to Vend’s clients. Vend has introduced Loop to all of their customers worldwide through their digital customer newsletter and some Vend customers have already begun the onboarding process with Loop. Vend is now expected to launch expanded sales and marketing campaigns in support of Loop and its API integration, explaining the benefits of Loop’s products and services to Vend’s growing customer list.
With Loop’s Insights, Engage, and Wallet pass platform all gaining interest from brands and retailers across the world, Vend will now be able to offer a simple onboarding process for retailers, drastically reducing the time required to integrate a new client and deploy Loop’s products and services.
On March 11th , Vend Director of Product Partnerships Lowry Gladwell joined the ‘Loop Experience’ podcast to discuss the benefits of Loop’s integration with the Vend API, particularly for franchisors looking to integrate multiple locations. Listen to the full episode here or read the full interview transcript here .
API Integration Will Accelerate Loop’s Growth in the $23-trillion Global Retail Market with Access to Over 155,000 Global Retail Clients
Loop Insights’ integration with the Vend Billing API will allow Loop to more rapidly onboard Vend’s growing client list in the $23-trillion global retail market .
On March 11th , Lightspeed POS Inc. (NYSE:LSPD) (TSX:LSPD), a leading provider of cloud-based, omnichannel commerce platforms, announced it had entered into a definitive agreement to acquire Vend. The acquisition will greatly expand Lightspeed’s existing foothold in Asia-Pacific, approximately doubling its existing customer base in that region.
The combination of Lightspeed’s scale with the talent and technology available to Vend, including Loop Insights’ products and services, is expected to greatly benefit Lightspeed and its massive customer base. Following the closing of the acquisition, Lightspeed will operate as the preferred technology provider for over 155,000 existing customer locations worldwide.
This press release is available on the Loop Insights Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/LoopInsights
About Vend Vend is a cloud-based point-of-sale and retail management software that lets retailers run their business in-store, online, and on-the-go. Vend includes inventory management, eCommerce integrations, customer loyalty, and reporting analytics tools. The first POS built for iOS, Vend is trusted by retailers in over 140 countries and is used in more than 20,000 customer locations worldwide. Vend integrates with leading tools like Bigcommerce, Quickbooks and Marsello and provides seamless integrated payment options by partnering with major banks and processors around the world. Founded in 2010, Vend has offices in Auckland, London, Toronto and Melbourne, and has raised more than $50 million from top-tier investors. For more information, please visit: https://www.vendhq.com/
About Loop Insights Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative automated marketing and contactless payment solutions built on artificial intelligence (“AI”) to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.
Posted by AGORACOM-JC
at 7:57 AM on Wednesday, April 7th, 2021
Patient count for March increased by 388%
Announced that patient counts increased by 460% in Q1 2021 (26,317) versus Q1 2020 (5,717).
Patient counts for the month of March increased by 388% versus the same period in 2020 with total patient counts of 8,379 in March 2021 compared to 2,160 in March 2020.
VANCOUVER BC / April 7, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(FRA:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce that patient counts increased by 460% in Q1 2021 (26,317) versus Q1 2020 (5,717). Patient counts for the month of March increased by 388% versus the same period in 2020 with total patient counts of 8,379 in March 2021 compared to 2,160 in March 2020.
“The delivery of world-class patient care is the number one priority for our team in all the markets we serve.” said Steven McAuley, Chairman & CEO of Empower. “I am so proud of our members’ daily effort and dedication to patients even in such uncertain times. For our team to achieve such significant year-over-year growth numbers is a testament to our ability to execute on our business plan to acquire patients and drive long-term shareholder value. I’m especially proud of the strong growth in the last month of Q1 which sets us up for continued growth in Q2 2021”
The Company has also issued a total of 800,000 stock options priced at $0.57 CAD to investor relation service providers and to a Director of the Company.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
